Highlights

[SLVEST] QoQ Quarter Result on 2020-09-30 [#2]

Stock [SLVEST]: SOLARVEST HOLDINGS BERHAD
Announcement Date 25-Nov-2020
Admission Sponsor -
Sponsor -
Financial Year 31-Mar-2021
Quarter 30-Sep-2020  [#2]
Profit Trend QoQ -     391.52%    YoY -     9.44%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 70,213 62,163 28,750 51,350 62,120 102,404 0 -
  QoQ % 12.95% 116.22% -44.01% -17.34% -39.34% 0.00% -
  Horiz. % 68.56% 60.70% 28.08% 50.14% 60.66% 100.00% -
PBT 7,165 5,708 1,286 2,845 4,834 4,516 0 -
  QoQ % 25.53% 343.86% -54.80% -41.15% 7.04% 0.00% -
  Horiz. % 158.66% 126.40% 28.48% 63.00% 107.04% 100.00% -
Tax -1,870 -1,642 -487 1,028 -532 -912 0 -
  QoQ % -13.89% -237.17% -147.37% 293.23% 41.67% 0.00% -
  Horiz. % 205.04% 180.04% 53.40% -112.72% 58.33% 100.00% -
NP 5,295 4,066 799 3,873 4,302 3,604 0 -
  QoQ % 30.23% 408.89% -79.37% -9.97% 19.37% 0.00% -
  Horiz. % 146.92% 112.82% 22.17% 107.46% 119.37% 100.00% -
NP to SH 5,027 4,001 814 3,814 3,978 3,656 0 -
  QoQ % 25.64% 391.52% -78.66% -4.12% 8.81% 0.00% -
  Horiz. % 137.50% 109.44% 22.26% 104.32% 108.81% 100.00% -
Tax Rate 26.10 % 28.77 % 37.87 % -36.13 % 11.01 % 20.19 % - % -
  QoQ % -9.28% -24.03% 204.82% -428.16% -45.47% 0.00% -
  Horiz. % 129.27% 142.50% 187.57% -178.95% 54.53% 100.00% -
Total Cost 64,918 58,097 27,951 47,477 57,818 98,800 0 -
  QoQ % 11.74% 107.85% -41.13% -17.89% -41.48% 0.00% -
  Horiz. % 65.71% 58.80% 28.29% 48.05% 58.52% 100.00% -
Net Worth 120,943 85,937 82,031 82,031 66,318 54,687 - -
  QoQ % 40.73% 4.76% 0.00% 23.69% 21.27% 0.00% -
  Horiz. % 221.15% 157.14% 150.00% 150.00% 121.27% 100.00% -
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 4,031 - - - - - - -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% - - - - - -
Div Payout % 80.20 % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% - - - - - -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 120,943 85,937 82,031 82,031 66,318 54,687 - -
  QoQ % 40.73% 4.76% 0.00% 23.69% 21.27% 0.00% -
  Horiz. % 221.15% 157.14% 150.00% 150.00% 121.27% 100.00% -
NOSH 403,145 390,624 390,624 390,624 331,593 390,624 - -
  QoQ % 3.21% 0.00% 0.00% 17.80% -15.11% 0.00% -
  Horiz. % 103.21% 100.00% 100.00% 100.00% 84.89% 100.00% -
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 7.54 % 6.54 % 2.78 % 7.54 % 6.93 % 3.52 % - % -
  QoQ % 15.29% 135.25% -63.13% 8.80% 96.87% 0.00% -
  Horiz. % 214.20% 185.80% 78.98% 214.20% 196.88% 100.00% -
ROE 4.16 % 4.66 % 0.99 % 4.65 % 6.00 % 6.69 % - % -
  QoQ % -10.73% 370.71% -78.71% -22.50% -10.31% 0.00% -
  Horiz. % 62.18% 69.66% 14.80% 69.51% 89.69% 100.00% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 17.42 15.91 7.36 13.15 18.73 26.22 - -
  QoQ % 9.49% 116.17% -44.03% -29.79% -28.57% 0.00% -
  Horiz. % 66.44% 60.68% 28.07% 50.15% 71.43% 100.00% -
EPS 1.25 1.02 0.21 0.98 1.20 1.25 0.00 -
  QoQ % 22.55% 385.71% -78.57% -18.33% -4.00% 0.00% -
  Horiz. % 100.00% 81.60% 16.80% 78.40% 96.00% 100.00% -
DPS 1.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% - - - - - -
NAPS 0.3000 0.2200 0.2100 0.2100 0.2000 0.1400 - -
  QoQ % 36.36% 4.76% 0.00% 5.00% 42.86% 0.00% -
  Horiz. % 214.29% 157.14% 150.00% 150.00% 142.86% 100.00% -
Adjusted Per Share Value based on latest NOSH - 633,953
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 11.08 9.81 4.54 8.10 9.80 16.15 - -
  QoQ % 12.95% 116.08% -43.95% -17.35% -39.32% 0.00% -
  Horiz. % 68.61% 60.74% 28.11% 50.15% 60.68% 100.00% -
EPS 0.79 0.63 0.13 0.60 0.63 0.58 0.00 -
  QoQ % 25.40% 384.62% -78.33% -4.76% 8.62% 0.00% -
  Horiz. % 136.21% 108.62% 22.41% 103.45% 108.62% 100.00% -
DPS 0.64 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% - - - - - -
NAPS 0.1908 0.1356 0.1294 0.1294 0.1046 0.0863 - -
  QoQ % 40.71% 4.79% 0.00% 23.71% 21.21% 0.00% -
  Horiz. % 221.09% 157.13% 149.94% 149.94% 121.21% 100.00% -
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 - 12/04/19 -
Price 1.8900 1.2200 1.5500 0.7300 0.7450 0.0000 0.8700 -
P/RPS 10.85 7.67 21.06 5.55 3.98 0.00 0.00 -
  QoQ % 41.46% -63.58% 279.46% 39.45% 0.00% 0.00% -
  Horiz. % 272.61% 192.71% 529.15% 139.45% 100.00% - -
P/EPS 151.57 119.11 743.82 74.77 62.10 0.00 0.00 -
  QoQ % 27.25% -83.99% 894.81% 20.40% 0.00% 0.00% -
  Horiz. % 244.07% 191.80% 1,197.78% 120.40% 100.00% - -
EY 0.66 0.84 0.13 1.34 1.61 0.00 0.00 -
  QoQ % -21.43% 546.15% -90.30% -16.77% 0.00% 0.00% -
  Horiz. % 40.99% 52.17% 8.07% 83.23% 100.00% - -
DY 0.53 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% - - - - - -
P/NAPS 6.30 5.55 7.38 3.48 3.73 0.00 0.00 -
  QoQ % 13.51% -24.80% 112.07% -6.70% 0.00% 0.00% -
  Horiz. % 168.90% 148.79% 197.86% 93.30% 100.00% - -
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date - 25/11/20 28/08/20 29/06/20 24/02/20 - - -
Price 2.4100 1.4600 1.1500 1.5500 1.2500 0.0000 0.0000 -
P/RPS 13.84 9.17 15.62 11.79 6.67 0.00 0.00 -
  QoQ % 50.93% -41.29% 32.49% 76.76% 0.00% 0.00% -
  Horiz. % 207.50% 137.48% 234.18% 176.76% 100.00% - -
P/EPS 193.27 142.54 551.86 158.75 104.20 0.00 0.00 -
  QoQ % 35.59% -74.17% 247.63% 52.35% 0.00% 0.00% -
  Horiz. % 185.48% 136.79% 529.62% 152.35% 100.00% - -
EY 0.52 0.70 0.18 0.63 0.96 0.00 0.00 -
  QoQ % -25.71% 288.89% -71.43% -34.38% 0.00% 0.00% -
  Horiz. % 54.17% 72.92% 18.75% 65.62% 100.00% - -
DY 0.41 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% - - - - - -
P/NAPS 8.03 6.64 5.48 7.38 6.25 0.00 0.00 -
  QoQ % 20.93% 21.17% -25.75% 18.08% 0.00% 0.00% -
  Horiz. % 128.48% 106.24% 87.68% 118.08% 100.00% - -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

605  230  568 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FOCUS 0.06-0.005 
 GOCEAN 0.0450.00 
 MTOUCHE 0.285+0.005 
 TANCO-WB 0.07+0.02 
 PERMAJU 0.1450.00 
 TANCO 0.145+0.01 
 MINDA 0.145+0.02 
 UCREST 0.30+0.005 
 TAWIN-OR 0.065-0.005 
 CAREPLS 2.41+0.05 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. FCPO FOR MAY 2021 NOW IS RM4,880 (TIME WHEN ALL GOES DOWN PALM OIL UP: SO BUY PALM OIL SHARES ON SALE, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
2. TWO POWERFUL FACTORS WHY PALM OIL BULL RUN CAN LAST MUCH LONGER THIS ROUND, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
3. OCK - The Unfaltering Tower OCK - The 5G Battle by Zyke42
4. Chinese Sinopharm broke Western Pharmaceutical Industry’s monopoly - Koon Yew Yin Koon Yew Yin's Blog
5. 这家小型股的股价在今年还可以再翻倍吗? Swim With Sharks
6. World’s largest pig farm in China will 'produce' 2 million pigs per year - Koon Yew Yin Koon Yew Yin's Blog
7. LUMBER PRICES TRIPLED SINCE LAST YEAR, WHO WILL BE THE BENEFICIARY? Swim With Sharks
8. China’s Sinovac shot found highly effective in real world study Good Articles to Share
PARTNERS & BROKERS